PITTSBURGH, Sept. 30 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ca…
Biopharmaceuticals, Generics, Neurology, FDA
Mylan, Mylan Pharmaceuticals, Carbidopa, Levodopa, Sinemet

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Mylan Receives FDA Approval for Generic Version of Parkinson’s Treatment Sinemet(R)”
Leave a Comment